Cystatin C, other markers of kidney disease, and incidence of age-related cataract

Archives of Ophthalmology

Volumn 126, Issue 12, 2008, Pages 1724-1730

  Klein, Barbara E K ^a   Knudtson, Michael D ^a   Brazy, Peter ^a   Lee, Kristine E ^a   Klein, Ronald ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; CYSTATIN C; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CHOLESTEROL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ADULT; AGED; AGING; ANAMNESIS; ARTICLE; CATARACT; CEREBRAL BLINDNESS; COHORT ANALYSIS; CONFIDENCE INTERVAL; CREATININE BLOOD LEVEL; DISEASE MARKER; EYE PHOTOGRAPHY; FEMALE; GENE; HUMAN; INCIDENCE; KIDNEY DISEASE; KIDNEY FUNCTION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; METABOLIC REGULATION; MULTIVARIATE ANALYSIS; MYDRIASIS; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RISK FACTOR; UREA NITROGEN BLOOD LEVEL; BLOOD; CLASSIFICATION; GLUCOSE BLOOD LEVEL; MIDDLE AGED;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD UREA NITROGEN; C-REACTIVE PROTEIN; CATARACT; CHOLESTEROL; CREATININE; CYSTATIN C; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INCIDENCE; KIDNEY DISEASES; MALE; MIDDLE AGED; RISK FACTORS;

EID: 58149234561     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2008.502     Document Type: Article

References (60)

1. Thylefors B, Negrel AD, Pararajasegaram R, Dadzie KY. Global data on blindness. Bull World Health Organ. 1995;73(1):115-121.
2. Rahmani B, Tielsch JM, Katz J, et al. The cause-specific prevalence of visual impairment in an urban population: the Baltimore Eye Survey. Ophthalmology. 1996;103(11):1721-1726.
3. Congdon N, Vingerling JR, Klein BE, et al. Prevalence of cataract and pseudophakia/aphakia among adults in the United States. Arch Ophthalmol. 2004;122(4):487-494.
4. Klein BE, Klein R, Jensen SC, Ritter LL. Are sex hormones associated with age-related maculopathy in women? the Beaver Dam Eye Study. Trans Am Ophthalmol Soc. 1994;92:289-295.
5. Hiller R, Sperduto RD, Ederer F. Epidemiologic associations with cataract in the 1971-1972 National Health and Nutrition Examination Survey. Am J Epidemiol. 1983;118(2):239-249.
6. Klein BE, Klein R, Ritter LL. Relationship of drinking alcohol and smoking to prevalence of open-angle glaucoma: the Beaver Dam Eye Study. Ophthalmology. 1993;100(11):1609-1613.
7. Christen WG, Manson JE, Seddon JM, et al. A prospective study of cigarette smoking and risk of cataract in men. JAMA. 1992;268(8):989-993.
8. Klein BE, Klein R, Moss SE. Prevalence of cataracts in a population-based study of persons with diabetes mellitus. Ophthalmology. 1985;92(9):1191-1196.
9. Klein BE, Klein R, Lee KE, Danforth LG. Drug use and five-year incidence of age-related cataracts: the Beaver Dam Eye Study. Ophthalmology. 2001;108(9):1670-1674.
10. De Juan E Jr, Sternberg P Jr, Michels RG. Penetrating ocular injuries: types of injuries and visual results. Ophthalmology. 1983;90(11):1318- 1322.
11. Duke-Elder S. System of Ophthalmology, Volume 14 . St Louis, MO: CV Mosby; 1972.
12. Wong TY, Klein BE, Klein R, Tomany SC. Relation of ocular trauma to cortical, nuclear, and posterior subcapsular cataracts: the Beaver Dam Eye Study. Br J Ophthalmol. 2002;86(2):152-155.
13. West SK, Duncan DD, Munoz B, et al. Sunlight exposure and risk of lens opacities in a population-based study: the Salisbury Eye Evaluation project. JAMA. 1998;280(8):714-718.
14. Taylor HR, West SK, Rosenthal FS, et al. Effect of ultraviolet radiation on cataract formation. N Engl J Med. 1988;319(22):1429-1433.
15. Klein BE, Cruickshanks KJ, Klein R. Leisure time, sunlight exposure and cataracts. Doc Ophthalmol. 1994-1995;88(3-4):295-305.
16. Iyengar SK, Klein BE, Klein R, et al. Identification of a major locus for age-related cortical cataract on chromosome 6p12-q12 in the Beaver Dam Eye Study. Proc Natl Acad Sci U S A. 2004;101(40):14485-14490.
17. Héon E, Paterson AD, Fraser M, et al. A progressive autosomal recessive cataract locus maps to chromosome 9q13-q22. Am J Hum Genet. 2001;68(3):772-777.
18. Klein BE, Klein R, Lee KE, Knudtson MD, Tsai MY. Markers of inflammation, vascular endothelial dysfunction, and age-related cataract. Am J Ophthalmol. 2006;141(1):116-122.
19. Klein BE, Klein R, Lee KE. Renal function abnormalities and incident cataract after a five-year interval: the Beaver Dam Eye Study. Curr Eye Res. 1998;17(7):720-725.
20. Durant JS, Frost NA, Trivella M, Sparrow JM. Risk factors for cataract subtypes waterclefts and retrodots: two case-control studies. Eye. 2006;20(11):1254-1267.
21. Clayton RM, Cuthbert J, Duffy J, et al. Some risk factors associated with cataract in SE Scotland: a pilot study. Trans Ophthalmol Soc U K. 1982;102(pt 3):331-336.
22. Vrabec R, Vatavuk Z, Pavlovic D, et al. Ocular findings in patients with chronic renal failure undergoing haemodialysis. Coll Antropol. 2005;29(suppl 1):95-98.
23. Klein BE, Klein R, Moss SE. Incidence of cataract surgery in the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Am J Ophthalmol. 1995;119(3):295-300.
24. Manetti L, Pardini E, Genovesi M, et al. Thyroid function differently affects serum cystatin C and creatinine concentrations. J Endocrinol Invest. 2005;28(4):346-349.
25. Knight EL, Verhave JC, Spiegelman D, et al. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int. 2004;65(4):1416-1421.
26. Coll E, Botey A, Alvarez L, et al. Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis. 2000;36(1):29-34.
27. Niccoli G, Conte M, Bona RD, et al. Cystatin C is associated with an increased coronary atherosclerotic burden and a stable plaque phenotype in patients with ischemic heart disease and normal glomerular filtration rate [published online ahead of print November 5, 2007]. Atherosclerosis. 2008;198(2):373-380. doi:10.1016/j.atherosclerosis.2007.09.022.
28. Sarnak MJ, Katz R, Stehman-Breen CO, et al. Cystatin C concentration as a risk factor for heart failure in older adults. Ann Intern Med. 2005;142(7):497-505.
29. Klein R, Klein BE, Linton KL, De Mets DL. The Beaver Dam Eye Study: visual acuity. Ophthalmology. 1991;98(8):1310-1315.
30. Klein R, Klein BE, Lee KE. Changes in visual acuity in a population: the Beaver Dam Eye Study. Ophthalmology. 1996;103(8):1169-1178.
31. Klein R, Klein BE, Lee KE, Cruickshanks KJ, Chappell RJ. Changes in visual acuity in a population over a 10-year period: the Beaver Dam Eye Study. Ophthalmology. 2001;108(10):1757-1766.
32. Klein R, Klein BE. The Beaver Dam Eye Study: Manual of Operations. Springfield, VA: US Dept of Commerce; 1991. National Technical Information Service Accession No. PB 91-149823/AS.
33. Klein R, Klein BE. The Beaver Dam Eye Study II: Manual of Operations. Springfield, VA: US Dept of Commerce; 1995. National Technical Information Service Accession No. PB 95-273827.
34. Klein R, Davis MD, Magli YL, Segal P, Klein BE, Hubbard L. The Wisconsin age-related maculopathy grading system. Ophthalmology. 1991;98(7):1128-1134.
35. Klein R, Davis MD, Magli YL, Segal P, Klein BE. The Wisconsin Age-Related Maculopathy Grading System. Springfield, VA: US Dept of Commerce; 1991. National Technical Information Service Accession No. PB 91-184267/AS.
36. Klein R, Klein BE, Linton KL. Prevalence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology. 1992;99(6):933-943.
37. Klein R, Klein BE, Jensen SC, Meuer SM. The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology. 1997;104(1):7-21.
38. Klein BE, Klein R, Linton KL, Magli YL, Neider MW. Assessment of cataracts from photographs in the Beaver Dam Eye Study. Ophthalmology. 1990;97(11):1428-1433.
39. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem. 1974;20(4):470-475.
40. Stein MW. D-glucose determination with hexokinase and glucose-6-phosphate dehydrogenase. In: Bergmeyer HC, ed. Methods of Enzymatic Analysis. New York, NY: Academic Press; 1963:117.
41. Klein R, Klein BE, Moss SE. Diabetes, hyperglycemia, and age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology. 1992;99(10):1527-1534.
42. Donahue RP, Stranges S, Rejman K, Rafalson LB, Dmochowski J, Trevisan M. Elevated cystatin C concentration and progression to pre-diabetes: the Western New York study. Diabetes Care. 2007;30(7):1724-1729.
43. Hosmer DW Jr, Lemeshow S. Special topics. In: Applied Logistic Regression. New York, NY: John Wiley & Sons; 1989:238-245.
44. Peduzzi M, Debbia A, Monzani A, et al. Prevalence of cataracts in a population-based study of patients with diabetes mellitus. Dev Ophthalmol. 1989;17:75-78.
45. Usui T, Hara M, Satoh H, et al. Molecular basis of ocular abnormalities associated with proximal renal tubular acidosis. J Clin Invest. 2001;108(1):107-115.
46. Himmelfarb J, Stenvinkel P, Ikizler TA, Hakim RM. The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int. 2002;62(5):1524-1538.
47. Ikizler TA, Morrow JD, Roberts LJ, et al. Plasma F2-isoprostane levels are elevated in chronic hemodialysis patients. Clin Nephrol. 2002;58(3):190-197.
48. Mezzano D, Pais EO, Aranda E, et al. Inflammation, not hyperhomocysteinemia, is related to oxidative stress and hemostatic and endothelial dysfunction in uremia. Kidney Int. 2001;60(5):1844-1850.
49. Costagliola C, Iuliano G, Menzione M, et al. Systemic human diseases as oxidative risk factors in cataractogenesis II: chronic renal failure. Exp Eye Res. 1990;51(6):631-635.
50. Hasan A, Smith JB, Qin W, Smith DL. The reaction of bovine lens alpha Acrystallin with aspirin. Exp Eye Res. 1993;57(1):29-35.
51. Barka T, van der Noen H. Expression of the cysteine proteinase inhibitor cystatin C mRNA in rat eye. Anat Rec. 1994;239(3):343-348.
52. Barka T, van der Noen H. Expression of the cysteine proteinase inhibitor cystatin C gene in rat heart: use of digoxigenin-labeled probes generated by polymerase chain reaction directly for in situ and northern blot hybridizations. J Histochem Cytochem. 1993;41(12):1863-1867.
53. Henskens YM, Veerman EC, Mantel MS, van der Velden U, Nieuw Amerongen AV. Cystatins S and C in human whole saliva and in glandular salivas in periodontal health and disease. J Dent Res. 1994;73(10):1606-1614.
54. Ix JH, Shlipak MG, Chertow GM, Whooley MA. Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study. Circulation. 2007;115(2):173-179.
55. Shlipak MG, Ix JH, Bibbins-Domingo K, Lin F, Whooley MA. Biomarkers to predict recurrent cardiovascular disease: the Heart and Soul Study. Am J Med. 2008;121(1):50-57.
56. Kahn HA, Leibowitz HM, Ganley JP, et al. The Framingham Eye Study II: association of ophthalmic pathology with single variables previously measured in the Framingham Heart Study. Am J Epidemiol. 1977;106(1):33-41.
57. Glynn RJ, Christen WG, Manson JE, Bernheimer J, Hennekens CH. Body mass index: an independent predictor of cataract. Arch Ophthalmol. 1995;113(9):1131-1137.
58. Miglior S, Bergamini F, Migliavacca L, Marighi P, Orzalesi N. Metabolic and social risk factors in a cataractous population: a case-control study. Dev Ophthalmol. 1989;17:158-164.
59. Klein BE, Klein R, Lee KE. Cardiovascular disease, selected cardiovascular disease risk factors, and age-related cataracts: the Beaver Dam Eye Study. Am J Ophthalmol. 1997;123(3):338-346.
60. Zeng J, Dunlop RA, Rodgers KJ, Davies MJ. Evidence for inactivation of cysteine proteases by reactive carbonyls via glycation of active site thiols. Biochem J. 2006;398(2):197-206.